Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

NORD Breakthrough Summit Features Bold New Ideas for the Future of Rare Disease Care, Policy and Research

National Organization for Rare Disorders (NORD) logo (PRNewsfoto/National Organization for Rare Disorders (NORD))

News provided by

National Organization for Rare Disorders (NORD®)

Oct 13, 2025, 09:30 ET

Share this article

Share toX

Share this article

Share toX

Lightning round poster presentations highlight cutting-edge insights on issues ranging from Medicaid coverage disparities to real-world data innovation

WASHINGTON, Oct. 13, 2025 /PRNewswire/ -- The future of rare disease advancements will take center stage at the National Organization for Rare Disorders (NORD®) Rare Disease and Orphan Products Breakthrough Summit®, Oct. 19-21 in Washington.

NORD is proud to announce the top researchers selected for the Lightning Rounds Poster Presentations session. Chosen from a competitive field of submissions by academics, researchers, industry, government agencies, health care professionals, patient organizations, and students, the winning posters represent the forefront of innovation and advocacy in the rare disease space.

The Lightning Rounds Poster Presentations, slated for Oct. 20, are a highlight of the annual NORD Breakthrough Summit. This year's selections reflect urgent and evolving priorities for the rare disease community, from addressing systemic barriers to genetic testing and harnessing real-world data for faster therapeutic discovery to creating collaborative care models that place patients at the center of innovation.

"These seven posters demonstrate what's possible when research, policy, and advocacy come together with a shared commitment to innovation and patient empowerment," said Pamela K. Gavin, NORD Chief Executive Officer. "We're proud to showcase such forward-thinking work at the NORD Breakthrough Summit and look forward to seeing how these insights drive collaboration and change for the rare disease community."

The winning posters and their authors are:

  • Partnering for Education at a Turning Point in the Desmoid Tumor Landscape
    (Presenting Author: Tariqa Ackbarali, PhD, CHCP, Medlive)
    This case study explores the power of partnership through a collaboration among Medlive, NORD, and the Desmoid Tumor Research Foundation to provide free, accredited, digital education. The outcomes revealed the impact on clinical teams, improving their ability to diagnose and treat desmoid tumors. 

  • The Castleman Disease Expert Panel: A Collaborative Model That Could Be Replicated to Improve Clinical Outcomes for Rare Disease Patients (Presenting Author: Madison Ahearn, BS, MHA, Castleman Disease Collaborative Network)
    This presentation explores how an expert panel was developed to assist physicians in improving diagnosis, treatment, and overall patient care for Castleman disease through open, discussion-based reviews of complex cases, while demonstrating a scalable model to improve outcomes across other rare diseases. 

  • Accelerating Rare Disease Discovery: Leveraging Real-World Data for Phenotypic Characterization and Therapeutic Target Identification (Presenting Author: Sanjay Ahuja, PhD, Regal Intel)
    Real-world data captured via electronic health records, patient registries, insurance claims, and more holds the key to accelerating the discovery and development of much-needed orphan products, this study concludes. 

  • Medicaid Coverage Gaps in Genetic Testing Lead to Health Disparities for Rare Disease (Presenting Author: Shannon Belmont, MPH, JM, GeneDx)
    This study reveals a "significant and persistent disparity" in access to outpatient exome and genome sequencing between individuals with commercial insurance and those covered by Medicaid. Since rare disease diagnoses already take years, these gaps may further delay diagnosis and treatment for medically underserved and vulnerable populations.

  • Streamlining Patient Engagement in Rare Disease: A Multi-Sponsor Advisory Panel Pilot (Presenting Author: Shana Dodge, PhD, The Association for Frontotemporal Degeneration)
    This pilot program brought together multiple companies to co-sponsor an advisory panel led by a patient advocacy organization, designed to efficiently gather insights from people affected by frontotemporal degeneration (FTD). The initiative streamlines input from a small patient population, reduces burden on individuals, and ensures clinical research reflects the real-world priorities of those living with FTD.

  • Quantifying Health Benefits of Orphan Drugs (Presenting Author: Genevieve Lyons, MSc, Alexion, AstraZeneca Rare Disease)
    This study finds that orphan drugs, especially those with single or multiple rare disease indications, offer significantly greater health benefits than non-orphan drugs, highlighting the importance of informed policymaking that incentivizes scientific innovation.

  • Spotlight on Familial Chylomicronemia Syndrome (FCS): Leveraging the Power of Individual Journeys Toward Collective Action—Voice of the Patient Paper (Presenting Author: Alexandra Roeser, Arrowhead Pharmaceuticals)
    To better understand the lived experience of those affected by familial chylomicronemia syndrome (FCS), Arrowhead Pharmaceuticals hosted a series of patient and caregiver convenings. Key insights highlight urgent needs for greater provider awareness and offer actionable strategies to improve diagnosis, care, and advocacy.

The Lightning Rounds Presentations, scheduled for Oct. 20 from 12-12:30 p.m. ET, is a dynamic, rapid-fire format designed to showcase the most compelling poster presentations in under five minutes each. This session is a cornerstone of the annual NORD Breakthrough Summit, offering visibility to rising voices and game-changing ideas across the rare disease space.

The NORD Breakthrough Summit, taking place at the Grand Hyatt in Washington, is an annual event dedicated to accelerating progress for the over 30 million Americans living with rare diseases.

This year's theme, "From Voices to Breakthroughs," underscores the power of lived experience in shaping scientific and policy progress. Featured speakers include patient advocates, industry executives, researchers at the forefront of scientific innovation, and regulatory leaders.

Learn more: https://nordsummit.org/

Media Registration:
If you are a member of an accredited media organization, please contact [email protected] to register for the NORD Breakthrough Summit.

About the National Organization for Rare Disorders
Founded in 1983, the National Organization for Rare Disorders (NORD®) is a leading independent, nonpartisan, nonprofit and patient advocacy organization dedicated to improving the health and lives of over 30 million Americans living with rare diseases. In partnership with more than 350 disease-specific member patient organizations, NORD drives progress in rare disease research, care, and policy. Learn more at https://rarediseases.org/

SOURCE National Organization for Rare Disorders (NORD®)

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

NORD Awards 2025 Seed Grants to Propel Breakthroughs in Rare Disease Research

NORD Awards 2025 Seed Grants to Propel Breakthroughs in Rare Disease Research

The National Organization for Rare Disorders (NORD®), in a move to accelerate breakthroughs for rare diseases lacking effective treatments, has...

NORD Unveils Free Data Literacy Course for the Rare Disease Community

NORD Unveils Free Data Literacy Course for the Rare Disease Community

The National Organization for Rare Disorders (NORD®), the leading national nonprofit serving more than 30 million Americans with rare diseases, today ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Trade Show News

Trade Show News

Not For Profit

Not For Profit

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.